Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Video

Can early treatment for MDS prevent progression to AML? If a patient receives early treatment for their MDS, does it still progress to aml in 1/3 of cases? Can you reduce the likelihood of MDS progressing to AML?

Posted by
HealthTree Logo HealthTree
• September 16, 2022

Description

Learn about availability of preventing MDS progression to AML in this HealthTree University lesson by a cancer specialist.

On this video

Transcript

Can early treatment for MDS prevent progression to AML? So can early treatment for MDS prevent the progression to AML? So we don't know for sure. As I said, not all patients are the same. It depends on the biology of the disease. If somebody has a high-risk MDS, particularly low blood counts, and also they have therapy-related MDS, or if they have high-risk cytogenetics like DELICION 17 or MONOZOMY 7, or if they have TP53 mutation. We know they have a high-risk disease. I think they need to be treated sooner than later. But for low-risk disease, we don't know for sure that treating early without any symptoms is beneficial. In fact, there was an old study that showed in low-risk patients, treating early is not beneficial. So I think it depends a little bit on the stage of the disease, whether it is high-risk or low-risk, at the beginning.

Related Content